Jeff Lagasse

Author's posts

Aetna, ACES team to launch Institute of Quality for autism care

Aetna has agreed to team up with Autism Comprehensive Educational Services to establish an Institute for Quality targeted toward individuals and families impacted by autism spectrum disorder, among other special needs.
Through the new national agreemen…

Idaho hospitals to get staffing boost to avoid crisis standards of care amidst COVID-19 surge

Idaho Governor Brad Little said the real solution to the crisis is more Idahoans choosing to receive COVID-19 vaccine.

Caregivers at three California Tenet Healthcare hospitals approve double-digit pay raises in new contracts

The caregivers had authorized a strike last month to improve staffing, pay, benefits and COVID-19-related health safeguards.

Cleveland Clinic sees $339 million profit in Q2, good for $1.3B in net income this year

Patient volume increases and cost reduction measures led to significant revenue increases, which were hampered in 2020 by COVID-19.

Health equity and the impact of COVID-19 top employer concerns for 2022

Access to mental healthcare and on-site medical clinics are also top-of-mind as employers anticipate future struggles.

COVID-19 surges put pressure on nonprofit hospital margins

More patients is resulting in a self-induced postponement of non-emergent surgical cases, resulting in lower hospital revenues.

Blue Cross NC’s Blue Premier program saved $197 million in 2020

The impact of Blue Premier appeared to grow last year as providers made gains in quality and cost measures.

Medicare Shared Savings Program ACOs saved $4.1 billion in 2020

ACOs also hit an average quality score of 97.8%, and 60 ACOs earned a perfect score of 100.

Existing technologies paved the way for mass vaccination efforts

Vaccine enthusiasm may have waned in recent months, with vaccine hesitancy prevalent among those who are reluctant to get their COVID-19 shots.

Existing technologies paved the way for mass vaccination efforts

For Arizona’s HonorHealth, distributing the COVID-19 vaccine was more about using what already existed.